Olson Mary Catherine, Korb Donald R, Greiner Jack V
Schepens Eye Institute, Harvard Medical School, Boston, MA, USA.
Eye Contact Lens. 2003 Apr;29(2):96-9. doi: 10.1097/01.ICL.0000060998.20142.8D.
Warm-compress therapy applied to the skin of the closed eyelids has been recommended as a treatment for meibomian gland dysfunction (MGD). Previous studies have evaluated the effects of warm-compress therapy on tear-film fluorescein break-up time and tear evaporation rate. The purpose of this study was to determine if tear-film lipid layer thickness (TFLLT) was altered following 5, 15, and 30 minutes of warm, moist compress therapy.
Twenty patients with a diagnosis of dry eye associated with MGD and a baseline TFLLT of <or= 90 nm (baseline difference between experimental and control eyes <or= 25 nm) were studied. The skin of the closed eyelids of one eye of each subject was treated for a total of 30 minutes with a compress saturated with warm (40.0 +/- 2.0 degrees C) water used as a compress; and the skin of the closed eyelids of the contralateral control eye was treated for a total of 30 minutes with a compress saturated with room-temperature (24.0 degrees C +/- 1.0 degrees C) water used as a compress. The subjects' eyes were randomized into experimental and control eyes. TFLLT was measured at the following time points: 5, 15, and 30 minutes during the 30-minute treatment period, and after 5 minutes following the 30-minute treatment period.
The mean baseline TFLLT of the experimental eye prior to treatment with a warm, moist compress was 57.8 +/- 12.9 (standard error) nm; after 5 minutes of treatment, TFLLT was 105.8 +/- 23.7 nm; after 15 minutes of treatment, 117.8 +/- 26.4 nm; after 30 minutes of treatment, 121.5 +/- 27.1 nm; and after 5 minutes following the 30-minute treatment, 96.0 +/- 21.5 nm. The mean baseline TFLLT of the control eye prior to treatment with a room temperature, moist compress was 63.0 +/- 14.1 nm; after 5 minutes of treatment, TFLLT was 63.8 +/- 14.3 nm; after 15 minutes of treatment, 62.3 +/- 13.9 nm; after 30 minutes of treatment, 64.5 +/- 14.4 nm; and after 5 minutes following the 30-minute treatment period, 58.5 +/- 13.1 nm. Using a paired-data t-test, the results demonstrated a significant increase in mean TFLLT in the experimental eye after 5 minutes (P < 0.001), 15 minutes (P < 0.001), and 30 minutes (P < 0.001) of treatment, and after 5 minutes following the 30-minute treatment period (P < 0.001) when compared to baseline TFLLT. In comparison, there was no significant increase in TFLLT of the control eye after 5 minutes (P = 0.79), 15 minutes (P = 0.77), and 30 minutes (P = 0.81) of treatment, and after 5 minutes following the 30-minute treatment period (P = 0.20) when compared to baseline TFLLT.
Warm, moist compress therapy applied to the skin of the closed eyelids increases TFLLT for subjects with MGD by more than 80%, 5 minutes after initiating treatment and an additional 20% after 15 minutes of treatment. This study supports clinical experience and previous reports on warm, moist compress therapy as an effective treatment for meibomian gland dysfunction.
已推荐对闭合眼睑皮肤进行热敷疗法来治疗睑板腺功能障碍(MGD)。先前的研究评估了热敷疗法对泪膜荧光素破裂时间和泪液蒸发率的影响。本研究的目的是确定在进行5、15和30分钟的温热湿敷疗法后,泪膜脂质层厚度(TFLLT)是否会发生改变。
研究了20例诊断为与MGD相关的干眼且基线TFLLT≤90 nm(实验眼与对照眼之间的基线差异≤25 nm)的患者。对每个受试者一只眼睛的闭合眼睑皮肤用饱和了温热(40.0±2.0℃)水的敷布进行总共30分钟的治疗;对侧对照眼的闭合眼睑皮肤用饱和了室温(24.0℃±1.0℃)水的敷布进行总共30分钟的治疗。受试者的眼睛被随机分为实验眼和对照眼。在以下时间点测量TFLLT:30分钟治疗期内的5、15和30分钟,以及30分钟治疗期后的5分钟。
实验眼在温热湿敷治疗前的平均基线TFLLT为57.8±12.9(标准误)nm;治疗5分钟后,TFLLT为105.8±23.7 nm;治疗15分钟后,为117.8±26.4 nm;治疗30分钟后,为121.5±27.1 nm;在30分钟治疗期后的5分钟,为96.0±21.5 nm。对照眼在室温湿敷治疗前的平均基线TFLLT为63.0±14.1 nm;治疗5分钟后,TFLLT为63.8±14.3 nm;治疗15分钟后,为62.3±13.9 nm;治疗30分钟后,为64.5±14.4 nm;在30分钟治疗期后的5分钟,为58.5±13.1 nm。使用配对数据t检验,结果表明与基线TFLLT相比,实验眼在治疗5分钟(P<0.001)、15分钟(P<0.001)和30分钟(P<0.001)后以及30分钟治疗期后的5分钟(P<0.001),平均TFLLT有显著增加。相比之下,对照眼在治疗5分钟(P = 0.79)、15分钟(P = 0.77)和30分钟(P = 0.81)后以及30分钟治疗期后的5分钟(P = 0.20),与基线TFLLT相比,TFLLT没有显著增加。
对闭合眼睑皮肤进行温热湿敷疗法可使MGD受试者的TFLLT在开始治疗5分钟后增加超过80%,在治疗15分钟后再增加20%。本研究支持了关于温热湿敷疗法作为睑板腺功能障碍有效治疗方法的临床经验和先前报告。